Dr Graeme John Finlay

MSc (Hons) PhD BTh

Research | Current

Research group

Teaching | Current

Course Director, MEDSCI 203, Mechanisms of Disease

Course Director, MEDSCI 101G, Environmental Threats to Human Health

Selected publications and creative works (Research Outputs)

As of 29 October 2020 there will be no automatic updating of 'selected publications and creative works' from Research Outputs. Please continue to keep your Research Outputs profile up to date.
  • Chen, Y. Y., Finlay, G. J., Kirker, J. A., Marshall, E. S., Richardson, E., & Baguley, B. C. (2011). In vivo and in vitro assessment of the action of SN 28049, a benzonaphthyridine derivative targeting topoisomerase II, on the murine Colon 38 carcinoma. INVESTIGATIONAL NEW DRUGS, 29 (6), 1504-1510. 10.1007/s10637-010-9509-0
    Other University of Auckland co-authors: Bruce Baguley
  • Drummond, C. J., Finlay, G. J., Broome, L., Marshall, E. S., Richardson, E., & Baguley, B. C. (2010). Action of SN 28049, a new DNA binding topoisomerase II-directed antitumour drug: comparison with doxorubicin and etoposide. Investigational New Drugs, 1-9.
    Other University of Auckland co-authors: Bruce Baguley
  • Bridewell, D. J. A., Porter, A. C. G., Finlay, G. J., & Baguley, B. C. (2008). The role of topoisomerases and RNA transcription in the action of the antitumour benzonaphthyridine derivative SN 28049. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 62 (5), 753-762. 10.1007/s00280-007-0660-z
    URL: http://hdl.handle.net/2292/17456
    Other University of Auckland co-authors: Bruce Baguley

Contact details

Primary office location

M&HS BUILDING 504 - Bldg 504
Level 0, Room 018
85 PARK RD
GRAFTON
AUCKLAND 1023
New Zealand